drugset / Trial / NCT06117514
Sudapyridine (WX-081) in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the safety, tolerability as well as pharmacokinetics of Sudapyridine (WX-081) in Chinese volunteers.
Timeline
- Start
- 2019-02-13
- Primary completion
- 2020-07-02
- Completion
- 2020-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sudapyridine | Unknown | 30 mg | Oral |
| Subject | Sudapyridine | Unknown | 100 mg | Oral |
| Subject | Sudapyridine | Unknown | 200 mg | Oral |
| Subject | Sudapyridine | Unknown | 300 mg | Oral |
Indications
No indication recorded.